SCIENTIFIC PROGRAM
| May 8, 2026 (Friday) |
||
| 13:30 – 14:00 | Session 1 – Opening Session | |
| 13:30 – 13:40 | Welcome | Huri Özdoğan |
| 13:40 – 14:00 | FMF, Bird’s Eye View | Ahmet Gül |
| 14:00 – 16:00 | Session 2 | Chairs: İzzet Fresko, Ahmet Gül |
| 14:00 – 14:30 | Is Geography Destiny? | Nükhet Varlık |
| 14:30 – 15:00 | How to Study the Impact of Enviromental Factors on Disease Phenotype? | Thomas Henry |
| 15:00 – 15:20 | How to Assess Field Surverys in FMF | Huri Özdoğan |
| 15:20 – 15:30 | Q&A | |
| 15:30 – 15:40 |
Oral Presentation Direct Ancient DNA Evidence of MEFV Variants in the Ancient City of Laodikeia, Western Anatolia |
Selçuk Yüksel |
| 15:40 – 16:10 | Coffee Break | |
| 16:10 – 17:10 | Session 3 | Chairs: Gökhan Keser, Kenan Barut |
| 16:10 – 16:40 | Last 2 years review: Basic science | Yelda Bilginer |
| 16:40 – 17:10 | Last 2 years review: Clinical Science | Özgür Kasapçopur |
| 17:10 – 17:55 | Session 4 | Chairs: Hasan Yazıcı, Melike Melikoğlu |
| 17:10 – 17:25 | Knowing What We Do Not Know | Hasan Yazıcı |
| 17:25 – 17:55 | Clinical Diagnosis Through the Brush of the Renaissance Painters and Beyond | Eldad Ben Chetrit (Online) |
| 17:55 – 18:25 | Project Discussion / Bosphorus Project | Project Working Group |
| May 9, 2026 (Saturday) | ||
| 08:30 – 10:00 | Session 5 | Chairs: Seza Özen, Eda Tahir Turanlı |
| 08:30 – 08:50 | Pyrin Inflammasome Activation and Its Regulation | Mohamed Lamkanfi |
| 08:50 – 09:00 | Q&A | |
| 09:00 – 09:20 | Challenges in Variant Interpretation and Speck-Seq Analysis | Thomas Henry |
| 09:20 – 09:30 | Q&A | |
| 09:30 – 09:50 | Significance of Heterozygous Patients in FMF | Seza Özen |
| 10:00 – 10:00 | Q&A | |
| 10:00 – 10:30 | Coffee Break | |
| 10:30 – 12:10 | Session 6 | Chairs: Thomas Henry, Cengiz Korkmaz, Fatoş Önen |
| 10:30-10:50 | FMF and Clonal Hematopoiesis | Sophie Georgin-Lavialle |
| 10:50 – 10:55 | Q&A | |
| 10.55 – 11:15 | FMF as an Inflammatory Immune Dysregulation Disorder | Sulaiman Al-Mayouf |
| 11:15 – 11:20 | Q&A | |
| 11:20-11:40 | The Smoldering Fire: Subclinical Inflammation | Helen Lachmann |
| 11:40 – 12:00 | Monitoring Inflammation: CRP and Beyond | Tilmann Kallinich |
| 12.00 – 12:10 | Q&A | |
| 12:10 – 12:40 | Proceutica Satallite Symposium  Use of Kineret in Colchicine-Resistant Patients – Clinical Experience and Case Studies Speaker: Abdurrahman Tufan |
Chairs: Ahmet Gül |
| 12:40 – 13:30 |
Lunch & Poster Tour and Poster Reviewing Group – I |
Chairs: Rafaelle Manna, Erbil Ünsal |
| 13:30 – 14:20 | Session 7 | Chairs: Özgür Kasapçopur, Banu Balcı-Peynircioğlu |
| 13:30 – 13:40 | Autoinflammatory Diseases Involving the Pyrin Inflammasome | Ahmet Gül |
| 13:50 – 13:55 | Q&A | |
| 13:55 – 14:15 | PFAPA, SURF and FMF | Marco Gattorno |
| 14:15 – 14:20 | Q&A | |
| 14:20 – 15:25 | Session 8 | Chairs: Helen Lachmann, Rafaelle Manna, Erbil Ünsal |
| 14:20 – 14:40 | FMF in Isolated Populations | Piero Portincasa |
| 14:40 – 14:55 | Differential Diagnosis of FMF in FMF-Prevalent Regions | Abdurrahman Tufan |
| 14:55 – 15:10 | Differential Diagnosis of FMF in Low-Prevalence Regions | Charalampia Papadopoulou |
| 15:10 – 15:25 | Q&A | |
| 15:25 – 15:55 | Coffee Break | |
| 16:00 – 17:00 | Session 9 | Chairs: Serdal Uğurlu, Charalampia Papadopoulou |
| 16:00 – 16:20 | Colchicine: Update | Eldad Ben-Chetrit (Online) |
| 16:20 – 16:30 | Q&A | |
| 16:30 – 16:50 | Real life data: Anti–IL-1 Agents in FMF | Betül Sözeri |
| 16:50 – 17:00 | Q&A | |
| 17:00 – 17:45 | Oral Presentations | Chairs: Yeşim Özgüler, Ezgi Özgün |
| Study of 34 prospective pregnancies in women receiving IL-1 inhibitors for systemic autoinflammatory diseases and comparison to unexposed pregnancies (GR2 study) | Marion Delplanque | |
| Functional testing of primary monocytes can distinguish healthy controls from patients with cryopyrin associated periodic syndrome (CAPS) and familial mediterranean fever (FMF) | Megan Sallows | |
| Familial Mediterranean Fever in Italy, Turkey, and Lebanon: a cross population analysis of genetics and clinical features. | Nour Jaber | |
| Long-Term Outcomes of Living Related Kidney Donors to Recipients with AA Amyloidosis Due to Familial Mediterranean Fever | Özgur Akin Oto | |
| 17:45 – | Session 10 | Chairs: Mikhail Kostik, Cemal Bes |
| 17:45 – 18:05 | Update: Treatment of AA Amyloidosis | Serdal Uğurlu |
| 18:05 – 18:25 | Management of Special Cases with Amyloidosis | Sophie Georgin-Lavialle |
| 18:25 – 18:35 | Q&A | |
| May 10, 2026 (Sunday) | ||
| 08:30 – 10:00 | Session 11 | Chairs: Marco Gattorno, Duygu Ersözlü |
| 08:30 – 08:50 | The Challenge to Treat FMF with Spondyloarthritis, PSA | Umut Kalyoncu |
| 08.50 -09.00 | Q&A | |
| 09:00 – 09:20 | Pros and Cons of Registries | Isabelle Kone Paut |
| 09:20 – 09.30 | Q&A | |
| 09:30 – 10:30 | Oral Presentations | Chairs: Nihal Esatoğlu, Betül Sözeri, Gülay Özgön |
| IL-1 Inhibitor goflikicept in familial Mediterranean fever: results of the phase 2 international randomized trial. | Serdal Uğurlu | |
| Definition of overlapping and mixed autoinflammatory disorders in patients carrying multiple autoinflammatory variants in a cohort of 483 patients followed at a tertiary referral centre. | Berşan Şen | |
| Mortality in Familial Mediterranean Fever in the Contemporary Era: Comparison with the General Population and Independent Predictors of Survival | Ozgur Can Kilinc | |
| Multi-omics profiling reveals selective CD16⁺ NK-cell collapse and TNF-driven apoptotic rewiring during Familial Mediterranean Fever flares | Zhicheng Zhou | |
| Real-world effectiveness of IL-17 antagonists in familial Mediterranean fever–associated inflammatory conditions | Burak Karakaya | |
| Investigating the cellular basis of colchicine resistance in FMF patients | Aysima Atilgan Lulecioglu | |
| Completed suicide with colchicine in familial Mediterranean fever: demographic, clinical, and post-mortem features | Berkay Aktaş | |
| Clinical Characteristics of Pediatric Patients with P369S/R408Q Mutation: A Single-Center Experience Across the FMF and PFAPA Spectrum | Atike Berra Mert | |
| 10:30 – 11:00 | Coffee Break | |
| 11:00 – 12:10 | Session 12 | Chairs: Tilmann Kallinich, Levent Kılıç |
| 11:00 – 11:30 | Compliance and Transition | Ömer Karadağ / Amra Androvich |
| 11:30 – 12:00 | Treatment Cessation in Patients with FMF | Nuray Aktay Ayaz |
| 12:00 – 12:10 | Q&A | |
| 12:10 – 13:25 | Session 13 | Chairs: Huri Özdoğan, Ahmet Gül |
| 12:10 – 12:25 | Bosphorus Project | Project Working Group |
| 12:25 – 12:40 | Research Agenda in EULAR Recommendations | Erdal Sağ |
| 12:40 – 13:00 | Review of the Meeting | Sezgin Şahin |
| 13:00 – 13:15 | Abstract Awards | Serdal Uğurlu |
| 13:15 – 13:30 | Closing: Future Perspective | Huri Özdoğan, Ahmet Gül, Eldad Ben-Chetrit |
| 13:30 – 14:30 | LUNCH | |
D Event Tourism Organization
Professional Congress Organizer (PCO)
İçerenköy Mah. Çayır Cad. No:5 Bay Plaza Kat:12
Ataşehir, İstanbul
Phone: +90 216 573 18 36
Web: www.devent.com.tr
e-mail: congress@devent.com.tr
D Event Tourism Organization